Accepted at: Feb, 04, 2025
10:01 a.m.
Author:
alexlewis
Related Deck:
1675118865074
Accepted
Rationale for new note
GOLD Guidelines
Text
GOLD Guidelines
Initial pharmacological treatment for COPD in a patient with moderate or worse symptoms and ≤2 moderate exacerbations yearly, without hospitalisation
{{c1::LABA + LAMA}}
Initial pharmacological treatment for COPD in a patient with moderate or worse symptoms and ≤2 moderate exacerbations yearly, without hospitalisation
{{c1::LABA + LAMA}}
Text
<b>GOLD Guidelines</b><br><u><i>Initial</i> pharmacological treatment</u> for <b>COPD</b> in a patient with <b>moderate or worse symptoms </b>and <b>≤2 moderate exacerbations yearly, <u>without</u> </b>hospitalisation<br><br>{{c1::LABA + LAMA}}
Extra
| ≥2 moderate exacerbations OR ≥1 leading to hospitalisation |
Group E LABA + LAMA
Consider LABA+LAMA+ICS if eosinophils ≥300μL
|
|
| ≤2 moderate exacerbations (not leading to hospital admission) |
Group A A bronchodilator |
Group B LABA + LAMA |
| mMRC 0-1, CAT <10 | mMRC ≥2, CAT ≥10 | |
Extra
<style>
/* Override Anki Night Mode */
:root {
--text-color: #000000 !important; /* Forces black text */
--bg-color: #ffffff !important; /* Forces white background */
}
strong {
font-size: clamp(10px, 2vw, 14px); /* Responsive text size */
text-transform: uppercase;
margin: 5px;
color: #155724;
display: inline-block;
}
.table-container {
display: flex;
justify-content: center;
align-items: center;
width: 100%;
overflow-x: auto; /* Allows scrolling on small screens */
}
table {
width: 100%;
max-width: 80%;
border-collapse: separate;
border-spacing: 8px;
background-color: var(--bg-color) !important; /* Prevents night mode inversion */
border-radius: 8px;
overflow: hidden;
box-shadow: 0px 2px 6px rgba(0, 0, 0, 0.2);
font-size: clamp(12px, 1.8vw, 16px); /* Responsive table text */
margin: auto;
display: block;
color: var(--text-color) !important; /* Prevents text color change */
}
th, td {
padding: 12px;
text-align: center;
border: 1px solid #ddd !important;
font-weight: normal;
font-style: normal;
border-radius: 6px;
color: var(--text-color) !important; /* Ensures text remains black */
}
.group {
background-color: #c3e6cb !important;
font-weight: bold;
text-align: center;
}
.criteria {
background-color: #f5c6cb !important;
}
th {
background-color: #007bff !important;
color: white !important;
font-weight: bold;
}
.hide-cell {
visibility: hidden;
border: none;
background: none;
}
.small-text {
font-size: clamp(10px, 1.5vw, 14px); /* Responsive small text */
display: block;
margin-top: 2px;
text-align: ;
}
/* Responsive Design for Mobile */
@media screen and (max-width: 600px) {
table {
font-size: clamp(10px, 2.5vw, 14px); /* Adjusts text for smaller screens */
max-width: 100%; /* Use full width */
}
th, td {
padding: 8px; /* Reduce padding for compact layout */
display: block; /* Ensures proper wrapping */
text-align: center;
}
.hide-cell {
display: none; /* Completely hides unnecessary empty cells */
}
}
</style>
<div class="table-container">
<table>
<tbody>
<tr class="criteria">
<td style="width: 40%;">≥2 moderate exacerbations <br>OR<br> ≥1 leading to hospitalisation</td>
<td colspan="2" class="group" style="width: 60%;">
<strong>Group E</strong><br>
<div class="small-text">LABA + LAMA</div>
<small class="small-text">Consider LABA+LAMA+ICS if eosinophils ≥300μL</small>
</td>
</tr>
<tr class="criteria">
<td style="width: 40%;">≤2 moderate exacerbations<br>(not leading to hospital admission)</td>
<td class="group" style="width: 30%;"><strong>Group A</strong><br>A bronchodilator</td>
<td class="group" style="width: 30%;"><strong>Group B</strong><br>LABA + LAMA</td>
</tr>
<tr class="criteria">
<td class="hide-cell"></td>
<td>mMRC 0-1, CAT <10</td>
<td>mMRC ≥2, CAT ≥10</td>
</tr>
</tbody>
</table>
</div>
Personal Notes
Empty field
Personal Notes
Missed Questions
Empty field
Missed Questions
Oxford Handbook
Empty field
Oxford Handbook
First Aid
Empty field
First Aid
AMBOSS
Empty field
AMBOSS
eTG Complete
Empty field
eTG Complete
Talley & O'Connor
Empty field
Talley & O'Connor
Additional Resources
Empty field
Additional Resources
Source
GOLD 2025 Report Accessed 31 January 2025
Source
<a href="https://goldcopd.org/2025-gold-report/">GOLD 2025 Report</a> Accessed 31 January 2025
One by one
Empty field
One by one
Tags
#Malleus_CM::#Guidelines::International::GOLD
#Malleus_CM::#Subjects::Respiratory_Medicine::05_Lungs::01_Obstructive::COPD::08_Diagnosis/Investigations
#Malleus_CM::#Resources_by_Rotation::Internal_Medicine::Respiratory_Medicine
#Malleus_CM::#Resources_by_Rotation::Internal_Medicine::General_Medicine
#Malleus_CM::#Resources_by_Rotation::Emergency
#Malleus_CM::#Resources_by_Rotation::Intensive_Care
#Malleus_CM::#Resources_by_Rotation::Internal_Medicine::Geriatric_Medicine
#Malleus_CM::#Resources_by_Rotation::General_Practice
#Malleus_CM::#Resources_by_Rotation::Internal_Medicine::Cardiology
#Malleus_CM::#Resources_by_Rotation::Internal_Medicine::Palliative_Care
#Malleus_CM::#Yield::High